Axtria, an AI-first data analytics innovator focused on transforming life sciences, has announced its highly anticipated ...

AstraZeneca's run of positive trial results with its cancer therapies has continued with a win for its immunotherapy Imfinzi ...

Gilead Sciences has joined the list of pharma groups hiking their capital investment plans in the US, adding $11 billion in ...

Cambridge, Massachusetts-based Vor Bio has confirmed that it will halt clinical and manufacturing operations, including its ...

Robert F Kennedy Jr has launched a project to trawl federal databases to try to identify why there has been an increase in ...

According to Politico, Trump will issue an executive order in the next few days to pursue the use of a so-called 'most ...

The metabolic effects of weight management medicines extend beyond appetite regulation. Still, with more questions about ...

Boehringer Ingelheim has started a proof-of-concept trial of a drug that could offer the first oral treatment for geographic ...

With the FDA and EMA releasing their annual reports detailing novel drug approvals in 2024, a new pharmaphorum podcast looks ...

For instance, studies have shown that approximately 25% of adults with diabetes reported rationing insulin in the previous ...

The UK exported £127 million in medicinal and pharmaceutical products to India in 2024, according to the organisation's ...

In a surprise post this afternoon, new FDA Commissioner Dr Martin Makary announced a completed pilot at the FDA of a ...